Itchy skin on Wegovy? What it means and what to do

Ready to take the next step? See if you're eligible for expert-led weight loss support.

Check your eligibility

Have you noticed itchiness when taking Wegovy (semaglutide)? Learn what's normal and when to be concerned.



Have you noticed itchiness when taking Wegovy (semaglutide)? Learn what's normal and when to be concerned.

It's quite typical for people taking Wegovy (semaglutide) to experience side effects – especially when starting treatment or changing their dose. Among the most common are nausea, constipation and upset stomach.¹


But there are less talked-about side effects, too – including injection site reactions.² In other words, you might experience swelling, sensitivity or itchiness of the skin around the place where you injected Wegovy. You may even notice small red bumps or an itchy rash.


In the vast majority of cases, these reactions are mild and should settle down after a couple of weeks. However, on very rare occasions, Wegovy can cause serious allergic reactions. If you suspect an allergic reaction, stop using Wegovy and seek medical advice straight away.


Why am I itchy after injecting Wegovy?

Skin is the first line of defence for your body, protecting you from the outside world. While medically safe, injecting a needle into your skin can send a signal that it needs to bolster its defensive barriers. 


When this happens, immune cells gather around the site. This can cause a small firm lump and itchiness. It's a normal immune response and should get better by itself after a few days. 


When it could be more than typical Wegovy itchy skin

If the pain is localised (only around the immediate injection area) and persists for several days, talk to your health provider or pharmacist. They can determine whether an antihistamine or other treatment is required.


If the injection site gets more painful or the skin becomes inflamed, scabs or leaks pus, this could be a sign of infection. Ask a medical professional to take a look as soon as possible.


Allergic reactions

Most people who experience itching around injection sites when taking Wegovy are experiencing typical bodily reactions to the injection. However, in rare cases, it could be a serious allergic reaction (anaphylaxis).


Always seek medical advice if you are unsure about any itching sensations, swelling or hotness. Stop taking the medication and seek medical help immediately if you think it's an allergic reaction to Wegovy. This may include any of the following symptoms: 

  • Severe itching or a severe rash
  • A red patch that tracks along the skin
  • Peeling or blistering skin (with or without a fever)
  • A swollen face, lips, tongue, mouth or throat
  • Difficulty breathing, talking or swallowing
  • A very rapid heartbeat
  • A tight chest
  • Wheezing
  • Feeling dizzy or fainting

On rare occasions, Wegovy can cause a skin sensitivity reaction that feels like burning or tingling. This is called "dysesthesia" and affected 2% of users in Wegovy clinical trials.³ If this happens, contact your health provider for advice. 


Follow instructions to minimise the risk of infection

It's important to follow directions carefully when taking Wegovy. This will help minimise the risk of injection site reactions and infections.

You'll receive full injection instructions with your Wegovy pen. We've also created this video to help you take Wegovy with confidence.

Are you taking Wegovy and thinking about switching to a different supplier? With SemaPen, you get access to tailored, expert advice throughout your weight loss journey. It's easy to find out if you're eligible by downloading the SemaPen app.

Sources


1. Wegovy.com (n.d.) What you might expect with Wegovy®. Retrieved from https://www.wegovy.com/obesity/is-wegovy-right-for-me/safety-side-effects.html


2. Novo Nordisk (2026) wegovy® FlexTouch® [patient information leaflet]. Retrieved from https://www.medicines.org.uk/emc/files/pil.13800.pdf


3. novoMEDLINK (n.d.) Efficacy & Safety. Retrieved from https://www.novomedlink.com/obesity/products/treatments/wegovy/efficacy-safety/safety-profile.html


This article was reviewed and approved by Sarah Abdula, Specialist Dietitian, on 3 February 2026.


  • Average 15-21% weight loss*
  • Tailored programmes built by real experts
  • Targeted support to make success feel simpler
  • Unique app with weight loss tools and lessons

Your journey starts here

Start your personalised weight loss plan in minutes.

1

Start your online consultation

2

Get approved by our clinical team

3

Begin your programme

Get started
While Wegovy and Mounjaro cause some muscle loss, there are as many myths as facts floating around.
by Simon Edward 25 May 2026
While Wegovy and Mounjaro cause some muscle loss, there are as many myths as facts floating around. Learn what one medical doctor has to say.
Discover what HDL cholesterol is, why it's considered 'good',
by Simon Edward 22 May 2026
Discover what HDL cholesterol is, why it's considered 'good', and how healthy lifestyle changes can support heart health.
How does metabolism influence weight loss? Learn about metabolic rate, calorie balance
by Simon Edward 18 May 2026
How does metabolism influence weight loss? Learn about metabolic rate, calorie balance and how to support your metabolism effectively.
Learn what foods to avoid and what to focus on with Mounjaro and Wegovy, including tips to support
by Simon Edward 15 May 2026
Learn what foods to avoid and what to focus on with Mounjaro and Wegovy, including tips to support safe, sustainable results.
The NHS has announced that 1.2 million more patients in England will be eligible for semaglutide
by Simon Edward 11 May 2026
The NHS has announced that 1.2 million more patients in England will be eligible for semaglutide by summer. Learn the facts behind the headline.
A new study suggests GLP-1 drugs like Mounjaro may improve asthma symptoms
by Simon Edward 8 May 2026
A new study suggests GLP-1 drugs like Mounjaro may improve asthma symptoms for those living with obesity. Join us as we unpack the results.
Wegovy patents are expiring in some parts of the world.
by Simon Edward 1 May 2026
Wegovy patents are expiring in some parts of the world. Does that mean we'll soon see cheaper generic versions in the UK?
In 2025, Novo Nordisk announced disappointing results from its semaglutide Alzheimer's trial.
by Simon Edward 1 May 2026
In 2025, Novo Nordisk announced disappointing results from its semaglutide Alzheimer's trial. But that's not the end of the story. Find out why.
Have you been told you're ineligible for weight loss drugs? Learn about your options and your rights
by Simon Edward 1 May 2026
Have you been told you're ineligible for weight loss drugs? Learn about your options and your rights, including asking for a second opinion on the NHS.
What's the safest way to dispose of weight loss pens and needles? Learn proper disposal methods
by Simon Edward 1 May 2026
What's the safest way to dispose of weight loss pens and needles? Learn proper disposal methods for Mounjaro and Wegovy in our UK guide.
More posts